Neuroendocrine neoplasm Clinical Trials

Delta Trials tracks 32 clinical trials for Neuroendocrine neoplasm in its publicly accessible dataset. Among the listed trials, 14 open for participant enrollment and 4 trials have reached completion. This research is carried out at 596 clinical sites around the world. An additional 14 trials have active registrations outside the recruiting and completed categories. Since 2020, 1 trial have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.